Stem Cell Research (Aug 2022)

Generation of an induced pluripotent stem cell line (MUSIi015-A) from a diabetic patient carrying mutations in ZYG11A (p.L475P) and GATA6 (p.E51K)

  • Siriwal Suwanpitak,
  • Chutima Chanprasert,
  • Ratchapong Netsrithong,
  • Nattachet Plengvidhya,
  • Pa-thai Yenchitsommanus,
  • Methichit Wattanapanitch,
  • Prapaporn Jungtrakoon Thamtarana

Journal volume & issue
Vol. 63
p. 102871

Abstract

Read online

Two heterozygous mutations (p.L475P in ZYG11A and p.E51K in GATA6) were identified in a family with autosomal dominant diabetes. ZYG11A-p.L475P was proposed as a causative mutation because of the complete segregation with hyperglycemia and the proven pathogenic effect on beta-cell expansion. The modifying effect of GATA6-p.E51K was proposed owing to the earlier onset of the carriers. Herein, we establish a line of induced pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells (PBMCs) of a proband who carries both mutations using Sendai viral vectors. The generated iPSC line was characterized for pluripotency, chromosomal normality, and authentication.

Keywords